The lead drug pricing negotiator at the White House said the overarching goal of TrumpRx is to improve price transparency, not to be a large

The US-headquartered, China-rooted biotech Earendil Labs said it has raised $787 million in private money, a whopping sum to fund an AI platform that has

The UK’s drug watchdog is reconsidering two Alzheimer’s disease medicines after rejecting them for being too expensive. The National Institute for Health and Care Excellence

Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.

The assets managed by Novo Holdings, the controlling shareholder of Novo Nordisk, fell by some 35% last year. But that doesn’t mean it will rein